Zum Hauptinhalt springen
Hochschulbibliothek der Hochschule Düsseldorf

Suchergebnisse

Katalog

Mehr
1.125 Treffer

Suchmaske

Suchtipp für den Bereich Mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Das folgende Suchfeld wird hier nicht unterstützt: "Signatur".

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Art der Quelle

Thema

Sprache

Inhaltsanbieter

1.125 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    Comprehensive Analysis of 177Lu-lilotomab Satetraxetan in Lymphoma Cell Lines: Implications for Precision Radioimmunotherapy and Combination Schemes.
    In: Immunotherapy Weekly, 2024-06-20, S. 221-221
    serialPeriodical
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    New Findings in Xenografts Described from Peking University Cancer Hospital and Institute ([<superscript>177</superscript>lu]Lu-labeled Anti-claudin-18.2 Antibody Demonstrated Radioimmunotherapy Potential In Gastric Cancer Mouse Xenograft Models).
    In: Immunotherapy Weekly, 2024-01-12, S. 401-401
    serialPeriodical
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    New Pancreatic Cancer Data Have Been Reported by Researchers at University of South Australia (In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer).
    In: Immunotherapy Weekly, 2023-09-05, S. 716-716
    serialPeriodical
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    Research from Texas Tech University Has Provided New Study Findings on Glioblastomas (Abstract 170: Glioblastoma patient-derived organoids as a model for discovering novel markers of therapy resistance in the context of tumor microenvironment:...).
    In: Immunotherapy Weekly, 2023-06-27, S. 783-783
    serialPeriodical
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    Adhering to mainstream concepts homeopathic therapy interpreted as a combination of non-specific and protein-based antigen-specific immunotherapy (Updated April 17, 2023).
    In: Immunotherapy Weekly, 2023-05-02, S. 193-193
    serialPeriodical
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    Researcher at University of Genova Releases New Study Findings on Acute Myeloid Leukemia (Harnessing Immune Response in Acute Myeloid Leukemia).
    In: Immunotherapy Weekly, 2023-09-25, S. 1739-1739
    serialPeriodical
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    Researcher at Analysis Group Inc. Describes Research in Ulcerative Colitis (Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the...).
    In: Immunotherapy Weekly, 2023-09-19, S. 1756-1756
    serialPeriodical
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    University of Sydney Researchers Yield New Study Findings on Lung Cancer (Anti-Tumor Activity of Novel Nimotuzumab-Functionalized Gold Nanoparticles as a Potential Immunotherapeutic Agent against Skin and Lung Cancers).
    In: Immunotherapy Weekly, 2023-09-14, S. 1749-1749
    serialPeriodical
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    Studies from Peking University Cancer Hospital and Institute Reveal New Findings on Melanoma (Five-Year Follow-Up of POLARIS-01 Phase II Trial: Toripalimab as Salvage Monotherapy in Chinese Patients With Advanced Melanoma).
    In: Immunotherapy Weekly, 2024-04-16, S. 1932-1932
    serialPeriodical
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    Mayo Clinic Researcher Releases New Data on Chronic Lymphocytic Leukemia (A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia).
    In: Immunotherapy Weekly, 2024-04-16, S. 1113-1113
    serialPeriodical
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    Report Summarizes Non-Small Cell Lung Cancer Study Findings from Centre Hospitalier Regional Universitaire (Incidence of venous thromboembolism and association with PD-L1 expression in advanced non-small cell lung cancer patients treated with...).
    In: Immunotherapy Weekly, 2024-01-23, S. 568-568
    serialPeriodical
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    Research Results from Nippon Medical School Update Understanding of Chemotherapy (Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced...).
    In: Immunotherapy Weekly, 2023-11-07, S. 2486-2486
    serialPeriodical
    Wie komme ich dran?
  13. Detailansicht für Treffer 13 öffnen
    A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases.
    In: Immunotherapy Weekly, 2023-10-17, S. 59-59
    serialPeriodical
    Wie komme ich dran?
  14. Detailansicht für Treffer 14 öffnen
    A Phase 1 Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of GEN1042 Monotherapy and in Combination With Pembrolizumab (+-) Chemotherapy in Japanese Subjects With Malignant Solid Tumors.
    In: Immunotherapy Weekly, 2023-10-17, S. 36-36
    serialPeriodical
    Wie komme ich dran?
  15. Detailansicht für Treffer 15 öffnen
    Researchers Submit Patent Application, "Human Non-Naturally Occurring Modified Fc Region Of Igg Specifically Binding To Non-Naturally Occurring Modified Fc Receptor", for Approval (USPTO 20230303658).
    In: Immunotherapy Weekly, 2023-10-17, S. 1726-1726
    serialPeriodical
    Wie komme ich dran?
  16. Detailansicht für Treffer 16 öffnen
    Researchers at Sahlgren's University Hospital Report New Data on Cancer (Estimating the Risk for Secondary Cancer After Targeted Alpha-therapy With At-211 Intraperitoneal Radioimmunotherapy).
    In: Immunotherapy Weekly, 2023-10-17, S. 961-961
    serialPeriodical
    Wie komme ich dran?
  17. Detailansicht für Treffer 17 öffnen
    Studies from University of Toronto Have Provided New Data on Prostate Cancer (Remodeling Tumor Immune Microenvironment by Using Polymer-Lipid-Manganese Dioxide Nanoparticles with Radiation Therapy to Boost Immune Response of...).
    In: Immunotherapy Weekly, 2023-10-17, S. 1127-1127
    serialPeriodical
    Wie komme ich dran?
  18. Detailansicht für Treffer 18 öffnen
    New Findings in Cancer Described from Bharathiar University (Tumor-targeted Conjugated Polymer Promotes Photothermal Immunogenic Cell Death and Release of the Tlr-9 Immunostimulant Induced Efficient Cancer Immunotherapy).
    In: Immunotherapy Weekly, 2023-10-17, S. 557-557
    serialPeriodical
    Wie komme ich dran?
  19. Detailansicht für Treffer 19 öffnen
    Report Summarizes Cancer Study Findings from Imam Mohammad Ibn Saud Islamic University (Advancements in MDM2 inhibition: Clinical and pre-clinical investigations of combination therapeutic regimens).
    In: Immunotherapy Weekly, 2023-10-17, S. 763-763
    serialPeriodical
    Wie komme ich dran?
  20. Detailansicht für Treffer 20 öffnen
    Reports from Second Affiliated Hospital of Nanchang University Advance Knowledge in Gastric Cancer (Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer).
    In: Immunotherapy Weekly, 2023-10-17, S. 801-801
    serialPeriodical
    Wie komme ich dran?

Weitere Bibliothekskataloge

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -